BioSpace News Archive

The study will be conducted at the Centre for Human Drug Research, in Leiden, Netherlands, with patient screening scheduled to begin this month.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), announced today that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its SARAQ™ Hepatitis B (HBV) Viral Load Kit.

Medidata, a Dassault Systèmes company, will be sharing insights into new decentralized clinical trials (DCTs) and AI technologies as a signature sponsor of the annual Summit for Clinical Ops Executives (SCOPE), February 7-10.

According to Emergen Research, the global electrosurgical devices market size was USD 4.80 billion in 2019 and is expected to reach USD 7.62 billion in 2027 and register a revenue CAGR of 6.3% during the forecast period.

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)- based DNA manufacturing and nucleic acid-based technologies, today announced that it will report fiscal 2022 first quarter financial results after market close on Thursday, February 10, 2022.

A clinical trial published this week demonstrated more than a 50% reduction in the incidence, severity, and duration of vocal cord injuries during thyroid cancer surgery when human amniotic membrane was used to protect the vocal cord nerve.